Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYAMUSE: NST001 (HYA) for Prevention of Postoperative Muscle Atrophy in Knee Cartilage Injury
jRCT2051230197Recruiting
- Sponsor
- Noster
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Osteochondritis dissecans of the knee (OCD), chondral knee defect and muscle atrophy comparing NST001 1200 mg BID with Placebo BID (2 arms). Started May 2024; status: recruiting.
02
Drugs
10-hydroxy-cis-7-dodecenoic acid
03
Conditions
Osteochondritis dissecans of the knee (OCD)chondral knee defectmuscle atrophy
Beyond the preview
Go deeper on jRCT2051230197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051230197.